HC Deb 08 January 2002 vol 377 c657W
Mr. Burns

To ask the Secretary of State for Health what plans he has for the possible use of aromatase inhibitors in the treatment of post-menopausal women suffering from breast cancer; and if he will make a statement. [24720]

Yvette Cooper

Aromatase inhibitors (eg Arimidex, Femera) are licensed for use in the United Kingdom for the treatment of advanced breast cancer in post menopausal women and so can be prescribed for use in the national health service for patients who meet the licensed criteria.

Mr. Burns

To ask the Secretary of State for Health if he will make a statement on the number of men who suffer from breast cancer in England. [24701]

Yvette Cooper

Breast cancer in men is very rare. Latest figures indicate 269 men were diagnosed with the disease in 1998.

Back to
Forward to